Request Deal Involvement

The consortium led by Mr. David Xiaoying Gao withdrew its offer to acquire China Biologic Products for $3.9bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

ICR

pr advisors

ICR

Conyers Dill & Pearman

legal advisors

Conyers Dill & Pearman

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Goldman Sachs

financial advisors

Goldman Sachs

or

Principals

TAIBANG BIOLOGIC GROUP (EX CHINA BIOLOGIC PRODUCTS HOLDINGS INC)

target

TAIBANG BIOLOGIC GROUP (EX CHINA BIOLOGIC PRODUCTS HOLDINGS INC)

GL CAPITAL GROUP

bidder

GL CAPITAL GROUP

CDH INVESTMENTS

bidder

CDH INVESTMENTS

MR. DAVID (XIAOYING) GAO

bidder

MR. DAVID (XIAOYING) GAO

BANK OF CHINA GROUP INVESTMENT LTD

bidder

BANK OF CHINA GROUP INVESTMENT LTD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - The consortium led by Mr. David Xiaoying Gao withdrew its offer to acquire China Biologic Products for $3.9bn.